Search

Abstract  After treatment with antimicrobial chemotherapy for the elimination of urinary multidrug-resistant Pseudomonas aeruginosa (MDRP), a 48-year-old man with recurrence of bladder cancer complained of acute onset of dyspnea, and computed tomography revealed multiple nodular lesions in the lung. Candida albicans was isolated from both urinary and blood samples. He was diagnosed as having a septic pulmonary embolism caused by C. albicans. Fungal septic pulmonary embolism is a rare condition; however, we must be cautious about superinfection as a consequence of strong antimicrobial chemotherapy, and understand that the treatment for urinary MDRP is likely to be difficult. [ABSTRACT FROM AUTHOR]

We have been producing the bifacial module, the HIT® Double, since 2000. This module was the first to be released in the world.1) We have since been developing high efficiency bifacial modules. We released a new bifacial photovoltaic (PV) module in 2013. It has a conversion efficiency of 16.0% in spite of having a light-through area of 8% within the total module area, and the temperature coefficient of the output power is quite good at −0.29%/°C. It passed various environmental tests that are much stricter than the industrial standard. Our field test showed the effectiveness of vertically installing the bifacial module, especially when installed on ground that highly reflects light such as snow or white limestone. We developed an original simulation method to accurately estimate the energy production of the bifacial module. A simulation accuracy of about 3.7% was confirmed through practical test results at our field test site in Niigata Prefecture, Japan. [ABSTRACT FROM AUTHOR]